red face articles ↓

One of the up and coming treatments for the redness of rosacea is the use of oxymetazoline based formulations. Oxymetazoline is the active ingredient in decongestant products like Afrin, Sudafed OM and Vick Sinex as well as …

Hot on the trail of the Phase 1 Study Results and Funding Announcement is a listing confirming that Vicept Therapeutics are soon to start dose finding trials for the treatment of the redness of rosacea. The trial will study the efficacy of V-101 Cream, applied once per day, at a low dose of 0.01%, 2 lots of mid-dose of 0.06% and 0.1%, …

With this latest press release, Vicept Therapeutics is now well and truly out in the public view, and attracting interest from rosacea sufferers. This release of results for Phase I trials of V-101 comes after news that Vicept Therapeutics had secured funding for the development of V-101.

Now that a company name has surfaced we can put the pieces together back to 2007 when Rosacea …

News across the business web sites today a new company obtaining funding for a patent protected alpha-adrenergic receptor based treatment for the redness of rosacea.

Vicept Therapuetics is based in Malvern in Pennsylvania and is a privately held company.
From Fidelity Biosciences Joins $10M Series A for Vicept Therapeutics

“We are delighted by the strong investor interest in this round of financing which will allow us to …

La Roche-Posay are not particularly well known in the rosacea world but they do sponsor the National Rosacea Society and have a range …